April 20, 2021
Akoya Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
MARLBOROUGH, Mass., April 20, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced the closing of its initial public offering of 7,567,000 shares of its common stock, including the exercise in full by the underwriters of their...

Continue Reading
April 15, 2021
Akoya Biosciences Announces Pricing of Initial Public Offering
MARLBOROUGH, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the pricing of its initial public offering of 6,580,000 shares of its common stock at a price of $20.00 per share, for gross proceeds of $131.6...

Continue Reading
April 5, 2021
Akoya Appoints Industry Leader Frederic Pla as Chief Operating Officer to Spearhead Growth Initiatives
Accomplished executive brings deep scientific and operational expertise Marlborough, MA. — April 5, 2021 — Akoya Biosciences, Inc., The Spatial Biology Company®, today announced the appointment of Frederic Pla, PhD, as Chief Operating Officer. Dr. Pla will play a key role in preparing the company...

Continue Reading
March 23, 2021
Akoya to Help Support the Human Cell Atlas (HCA) Initiative with Single-Cell, Spatial Imaging Capabilities
CODEX’s spatial phenotyping capabilities will contribute to HCA investigators’ ability to build comprehensive tissue maps. MARLBOROUGH, Mass. — March 23, 2021 — Akoya Biosciences, Inc., The Spatial Biology Company®, today announced its support for the Human Cell Atlas (HCA) initiative, offering the...

Continue Reading
March 2, 2021
Akoya and Johns Hopkins’ Collaborative Agreement Supports Pioneering New Approach to Immunotherapy Biomarker Discovery and Validation
Astronomy and Pathology (AstroPath™) come together for the first time to discover and clinically validate new spatial phenotypic signatures using multiplex immunofluorescence. MARLBOROUGH, Mass. — March 2, 2021   —  Akoya Biosciences, Inc., The Spatial Biology Company®, today announced a...

Continue Reading
January 11, 2021
Akoya Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021
MENLO PARK, Calif. — January 11, 2021  — Akoya Biosciences, Inc., The Spatial Biology Company®, today announced that Brian McKelligon, the company’s Chief Executive Officer, is scheduled to present at the J.P. Morgan 39th Annual Healthcare Conference on Wednesday, January 13, 2021. Mr....

Continue Reading

Search Investor Relations